Patents by Inventor John Sereno

John Sereno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4310462
    Abstract: A process to produce methyl 3,4-anhydro-2,6-dideoxy-L-ribohexopyranoside, its enantiomer and racemate thereof.The compound is useful as an intermediate in the production of daunosamine which in turn is a prime constituent in the anti-cancer agents Daunomycin and Adriamycin. Also disclosed are novel intermediates in the process.
    Type: Grant
    Filed: October 17, 1980
    Date of Patent: January 12, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Guenter Grethe, Milan R. Uskokovic, John Sereno
  • Patent number: 4238399
    Abstract: A process to produce methyl 3,4-anhydro-2,6-dideoxy-L-ribohexopyranoside, its enantiomer and racemate thereof.The compound is useful as an intermediate in the production of daunosamine which in turn is a prime constituent in the anti-cancer agents Daunomycin and Adriamycin. Also disclosed are novel intermediates in the process.
    Type: Grant
    Filed: June 13, 1979
    Date of Patent: December 9, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Guenter Grethe, Milan R. Uskokovic, John Sereno
  • Patent number: 4228080
    Abstract: A process to produce methyl 3,4-anhydro-2,6-dideoxy-L-ribohexopyranoside, its enantiomer and racemate thereof.The compound is useful as an intermediate in the production of daunosamine which in turn is a prime constituent in the anti-cancer agents Daunomycin and Adriamycin. Also disclosed are novel intermediates in the process.
    Type: Grant
    Filed: June 13, 1979
    Date of Patent: October 14, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Guenter Grethe, Milan R. Uskokovic, John Sereno
  • Patent number: 4174344
    Abstract: A process to produce methyl 3,4-anhydro-2,6-dideoxy-L-ribohexopyranoside, its enantiomer and racemate thereof.The compound is useful as an intermediate in the production of daunosamine which in turn is a prime constituent in the anti-cancer agents Daunomycin and Adriamycin. Also disclosed are novel intermediates in the process.
    Type: Grant
    Filed: November 14, 1977
    Date of Patent: November 13, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Guenter Grethe, Milan R. Uskokovic, John Sereno